BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 17, 2010
View Archived Issues
First oral anaphylatoxin C5a receptor antagonist CCX-168 is safe in phase I trial
Read More
EMA orphan drug status for SBC-102 in LAL deficiency / News in Context
Read More
Preclinical studies evaluate Cz-007, Cz-008 and Cz-009 for treatment of Chagas' disease
Read More
Preclinical and first-in-human data reported on antimalarial OZ-439
Read More
ProStrakan provides update on Orexo's Abstral for cancer pain
Read More
GSK and Fiocruz expand collaboration to develop new drugs for tropical diseases
Read More
SUN-13837 accelerates functional recovery in rat models of spinal cord injury and stroke
Read More
FDA approves Vyvanse for ADHD in adolescents
Read More
Wyeth describes new PI3K-alpha/gamma and mTOR inhibitors
Read More
Isis and Xenon Pharma to develop hemojuvelin- and hepcidin-targeted drugs for anemia of inflammation
Read More
FDA grants orphan drug status to MP4CO for painful crises of sickle cell disease
Read More
Isotechnika and ILJIN to codevelop voclosporin for transplant indications
Read More
AtheroNova and Cedars-Sinai Heart Institute partner on treatment to reduce arterial plaques
Read More
Albert Einstein College of Medicine claims new Tim16 inhibitors
Read More
Infinity Pharma advances phase Ib/II IPI-926 trial in pancreatic cancer
Read More
InteRNA Technologies receives grant from Dutch government to develop miRNA-based therapeutics
Read More
Ono Pharma begins phase II trial of subcutaneous methylnaltrexone in Japan
Read More
ReNeuron treats first patient in phase I trial of ReN-001 stem cells in stroke
Read More
Lilly presents new inhibitors of 5HTT and NET
Read More
Angioblast Systems receives U.S. government grants for five stem cell projects
Read More
Janssen discloses new chemokine CCR2 receptor antagonists
Read More
Targeted Genetics enters agreement to acquire Biocontrol
Read More
Enrollment complete in ORACLE MS trial of cladribine tablets
Read More
EMA approves Cell Therapeutics' pediatric investigation plan for Pixuvri
Read More
Phosphasgenics and 3M Pharma join to develop oxycodone pain patch
Read More